BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 32457836)

  • 1. High Levels of HIST1H2BK in Low-Grade Glioma Predicts Poor Prognosis: A Study Using CGGA and TCGA Data.
    Liu W; Xu Z; Zhou J; Xing S; Li Z; Gao X; Feng S; Xiao Y
    Front Oncol; 2020; 10():627. PubMed ID: 32457836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
    Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
    BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Systematic Landscape of Nectin Family and Nectin-Like Molecules: Functions and Prognostic Value in Low Grade Glioma.
    Han Y; Zou C; Zhu C; Liu T; Shen S; Cheng P; Cheng W; Wu A
    Front Genet; 2021; 12():718717. PubMed ID: 34925438
    [No Abstract]   [Full Text] [Related]  

  • 4. Next-generation sequencing identifies HOXA6 as a novel oncogenic gene in low grade glioma.
    Xiulin J; Wang C; Guo J; Wang C; Pan C; Nie Z
    Aging (Albany NY); 2022 Mar; 14(6):2819-2854. PubMed ID: 35349479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.
    Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C
    Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated expression of mitochondrial transcription elongation factor (TEFM) predicts poor prognosis in low grade glioma-an analysis of the Cancer Genome Atlas (TCGA) dataset.
    Li S; Wang W; Zi J; Sun M; Mei W; Yang N; Zhang R; Yu M; Xiong W
    Transl Cancer Res; 2020 May; 9(5):3610-3622. PubMed ID: 35117724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADPRH is a prognosis-related biomarker and correlates with immune infiltrates in low grade glioma.
    Zhang C; Wang L; Liu H; Deng G; Xu P; Tan Y; Xu Y; Liu B; Chen Q; Tian D
    J Cancer; 2021; 12(10):2912-2920. PubMed ID: 33854592
    [No Abstract]   [Full Text] [Related]  

  • 8. HAUS Augmin-Like Complex Subunit 1 Influences Tumour Microenvironment and Prognostic Outcomes in Glioma.
    Yao Q; Ge X; Lu Z; Shi J; Shen J; Chen J
    J Oncol; 2022; 2022():8027686. PubMed ID: 35865089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [IgG Fc binding protein (FCGBP) as a prognostic marker of low-grade glioma and its correlation analysis with immune infiltration].
    Liu Q; Zhang J; Zhang F; Zhang W; Gong L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Aug; 39(8):686-692. PubMed ID: 37515334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Analysis of Inflammatory Response-Related Genes, and Prognosis and Immune Infiltration in Patients With Low-Grade Glioma.
    Han T; Zuo Z; Qu M; Zhou Y; Li Q; Wang H
    Front Pharmacol; 2021; 12():748993. PubMed ID: 34712139
    [No Abstract]   [Full Text] [Related]  

  • 11. High Expression of C1ORF112 Predicts a Poor Outcome: A Potential Target for the Treatment of Low-Grade Gliomas.
    Zhang Z; Tan Z; Lv Q; Wang L; Yu K; Yang H; Liang H; Lu T; Ji Y; Chen J; He W; Chen Z; Chen S; Shen X
    Front Genet; 2021; 12():710944. PubMed ID: 34880897
    [No Abstract]   [Full Text] [Related]  

  • 12. CKMT1B is a potential prognostic biomarker and associated with immune infiltration in Lower-grade glioma.
    Shi H; Song Y; Song Z; Huang C
    PLoS One; 2021; 16(1):e0245524. PubMed ID: 33465115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Level of METTL7B Indicates Poor Prognosis of Patients and Is Related to Immunity in Glioma.
    Xiong Y; Li M; Bai J; Sheng Y; Zhang Y
    Front Oncol; 2021; 11():650534. PubMed ID: 33996568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New biomarker: the gene HLA-DRA associated with low-grade glioma prognosis.
    Chen D; Yao J; Hu B; Kuang L; Xu B; Liu H; Dou C; Wang G; Guo M
    Chin Neurosurg J; 2022 May; 8(1):12. PubMed ID: 35585639
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Liu B; Su Q; Xiao B; Zheng G; Zhang L; Yin J; Wang L; Che F; Heng X
    Front Oncol; 2021; 11():657029. PubMed ID: 34912698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PBX3 as a biomarker for the early diagnosis and prediction of prognosis of glioma.
    Pan C; Bai X; Li N; Zheng N; Si Y; Zhao Y
    PLoS One; 2024; 19(2):e0293647. PubMed ID: 38324550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of VASH1 as a Potential Prognostic Biomarker of Lower-Grade Glioma by Quantitative Proteomics and Experimental Verification.
    Aili Y; Maimaitiming N; Maimaiti A; Liu W; Qin H; Ji W; Mahemuti Y; Wang Y; Wang Z
    J Oncol; 2022; 2022():2621969. PubMed ID: 36504559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and Prognostic Value of ARID5A and its Correlation With Tumor-Infiltrating Immune Cells in Glioma.
    Zhou Q; Zhou J; Fan J
    Front Oncol; 2021; 11():638803. PubMed ID: 34094918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.
    Cheng W; Li M; Jiang Y; Zhang C; Cai J; Wang K; Wu A
    J Neurosurg; 2016 Jul; 125(1):7-16. PubMed ID: 26544773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Bioinformatic Analysis: The Overexpression and Prognostic Potential of
    Zhao Q; Zhang L; Wang Y; Sun Y; Wang T; Cao J; Qi M; Du X; Xia Z; Zhang R; Yang Y
    Int J Gen Med; 2022; 15():4321-4337. PubMed ID: 35480989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.